Biosimilar Manufacturing
Biosimilar Manufacturing is the biopharmaceutical production process that involves the development and synthesis of highly similar versions of approved biological reference products through recombinant DNA technology, cell culture, and rigorous analytical characterization to ensure comparable quality, safety, and efficacy.
50
Publications
1.8K
Citations
276
Authors
161
Institutions
Publications per year
2017–2026
15
Parents
50
Erwin A. Blackstone, P Fuhr Joseph · PubMed · 2013 · 177 citations
Bhupinder Singh Sekhon, Vikrant Saluja · Biosimilars · 2011 · 95 citations · Full text
Development of a new G-CSF product based on biosimilarity assessment
Pere Gascón, Uwe Fuhr, F. Sörgel et al. · Annals of Oncology · 2009 · 90 citations · Full text
1–5 of 50
276
3
h-index
2
h-index
2
h-index
2
h-index
2
h-index
1–5 of 276
161
Indian Institute of Technology Delhi
New Delhi, India
3 h-index
7 publications
186 citations
KU Leuven
Leuven, Belgium
2 h-index
6 publications
554 citations

University of Toronto
Toronto, Canada
2 h-index
3 publications
73 citations
Prevea Health
Green Bay, United States
2 h-index
2 publications
56 citations
Université Paris Cité
Paris, France
2 h-index
2 publications
67 citations
Duke University
Durham, United States
2 h-index
3 publications
85 citations

University of Rome Tor Vergata
Rome, Italy
1 h-index
1 publications
24 citations
Medical University of Lodz
Lodz, Poland
1 h-index
2 publications
38 citations
1–8 of 161
Repository · 7 publications · 342 citations
7
h-index
4 publications · 160 citations
4
h-index
2 publications · 130 citations
2
h-index
2 publications · 28 citations
2
h-index
2 publications · 119 citations
2
h-index
1–5